SCHEMBL5504865

SCHEMBL5504865

CCCCn1ncc2c(oc3c(OC(F)F)ccc(C(=O)OCC)c32)c1=O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
PDE4B Q07343 3/20 0.36
PDE5A O76074 1/20 0.36
PDE4A P27815 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL73992 0.91 PDE4B (0.39) PDE4BPDE5APDE4APDE4CPDE4D
SCHEMBL75082 0.83 ALDH1A1 (0.44) ALDH1A1HTTPDE4BPDE4APDE4C
SCHEMBL85521 0.82 PDE4D (0.54) PDE4BPDE4APDE4CPDE4D
SCHEMBL3873741 0.81 PDE4B (0.36) ALDH1A1PDE4BPDE4APDE4CPDE4D
SCHEMBL73417 0.80 PDE4D (0.38) PDE4BPDE5APDE4APDE4CPDE4D
SCHEMBL73450 0.78 ALDH1A1 (0.39) ALDH1A1HTTPDE4BPDE4APDE4C
SCHEMBL15041024 0.76 BACE1 (0.32) PDE4BPDE4APDE4CPDE4D
SCHEMBL73771 0.76 PDE4D (0.40) ALDH1A1PDE4BPDE4APDE4CPDE4D
SCHEMBL73046 0.75 PDE4D (0.44) ALDH1A1PDE4BPDE4APDE4CPDE4D
SCHEMBL75050 0.69 PDE4D (0.41) ALDH1A1HTTPDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831227-B1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS SA (CH) 2013-06-19 EP claimed
EP-1831227-B1 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS SA (CH) 2013-06-19 EP disclosed
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 EP disclosed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 WO disclosed